ÎÚÑ»´«Ã½

(WASHINGTON, Feb. 1, 2024) — The ÎÚÑ»´«Ã½ (ASH) today announced the 36 recipients of its 2024 Scholar Awards. One of ASH’s most prestigious research award programs, the ASH Scholar Award supports early career investigators dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.

Each Scholar Award provides $100,000 for the Fellow level, $125,000 for the Fellow to Faculty Scholars level, and $150,000 for the Junior Faculty level. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that advances the understanding and treatment of blood disorders. 

“The ASH Scholar Award offers crucial support, resources, and mentorship to emerging scholars during their transition from training to establishing independent careers as investigators in hematology. Through this award, ASH recognizes their remarkable contributions and acknowledges their potential to transform the field,” said 2024 ASH President, Mohandas Narla, DSc, of New York Blood Center Enterprises. “For decades, ASH has paved the way for fellows and early career faculty to have a lasting impact on hematology. We congratulate this year’s recipients and are excited to see how they improve the lives of individuals living with blood disorders.”

The 2024 Scholar Awards recipients are:

Basic/Translational Research Fellows
Joshua Brandstadter, MD, PhD, University of Pennsylvania
Nicoletta Cieri, MD, PhD, Dana-Farber Cancer Institute
David Glass, PhD, Fred Hutchinson Cancer Center
Xu Han, PhD, Case Western Reserve University School of Medicine
Mariia Kumskova, MD, The University of Iowa
Kentson Lam MD, PhD, University of California San Diego
Pengfei Liang, PhD, Duke Medical Center
Xinjian Mao, PhD, Stowers Institute for Medical Research
Jeremy Meier, MD, PhD, The University of North Carolina
Caner Saygin, MD, The University of Chicago
Michael Tassia, PhD, Johns Hopkins University

Basic/Translational Fellow to Faculty Scholars 
Andres Chang, MD, PhD, Winship Cancer Institute of Emory University
Saravanan Ganesan, PhD, Weill Cornell Medicine
Sascha Haubner, MD, Memorial Sloan Kettering Cancer Center
Yafeng Li, PhD, The University of Texas Southwestern Medical Center
Erin Parry, MD, PhD, Dana-Farber Cancer Institute

Basic/Translational Research Junior Faculty Scholars
Robert Bowman, PhD, University of Pennsylvania
Francesca Ferraro, MD, PhD, Washington University in St. Louis
Harinad Maganti, PhD, Canadian Blood Services
Linde Miles, PhD, Cincinnati Children's Hospital
Patrizia Mondello, MD, PhD, Mayo Clinic
Zuzana Tothova, MD, PhD, Dana-Farber Cancer Institute
Kim Vanuytsel, PhD, Boston University Chobanian & Avedisian School of Medicine / Boston Medical Center
Aaron Viny, MD, MS, Columbia University Irving Medical Center
Albert Yeh, MD, Fred Hutchinson Cancer Center

Clinical Research Fellow
Michelle Lee, MD, Massachusetts General Hospital

Clinical Research Fellow to Faculty Scholars
Christopher Su, MD, MPH, University of Washington / Fred Hutchinson Cancer Center

Clinical Research Junior Faculty Scholars
Ghaith Abu Zeinah, MD, The New York-Presbyterian Hospital / Weill Cornell University
Susanna Curtis MD, PhD, Icahn School of Medicine at Mount Sinai
Natalie Grover, MD, The University of North Carolina
Swetha Kambhampati, MD, City of Hope National Medical Center
Madhavi Lakkaraja, MD, MPH, Fred Hutchinson Cancer Center
Ang Li, MD, MS, Baylor College of Medicine
Reid Merryman, MD, Dana-Farber Cancer Institute
Melody Smith, MD, MS, Leland Stanford Junior University
Shaina Willen, MD, University of California Davis Medical Center

ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH gratefully acknowledges AstraZeneca for supporting this award.

ASH commits approximately $13 million annually in support of the careers of the next generation of leaders in the field of hematology through the Society’s awards and career development programs. 

The ÎÚÑ»´«Ã½ (ASH) (hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology.  

ASH’s flagship journal, Blood () is the most cited peer-reviewed publication in the field, and Blood Advances () is an open-access, online journal that publishes more peer-reviewed hematology research than any other academic journal worldwide. In 2024, two new journals joined the Blood Journals portfolio, Blood Neoplasia () and Blood Vessels, Thrombosis & Hemostasis (). 

Contact:
Kira Sampson, ÎÚÑ»´«Ã½
[email protected]; 202-499-1796